IL83819A - Acetic acid ester of haloperidol and pharmaceutical compositions thereof - Google Patents
Acetic acid ester of haloperidol and pharmaceutical compositions thereofInfo
- Publication number
- IL83819A IL83819A IL83819A IL8381987A IL83819A IL 83819 A IL83819 A IL 83819A IL 83819 A IL83819 A IL 83819A IL 8381987 A IL8381987 A IL 8381987A IL 83819 A IL83819 A IL 83819A
- Authority
- IL
- Israel
- Prior art keywords
- haloperidol
- pharmaceutical compositions
- acetic acid
- acid ester
- compounds
- Prior art date
Links
- LNEPOXFFQSENCJ-UHFFFAOYSA-N haloperidol Chemical compound C1CC(O)(C=2C=CC(Cl)=CC=2)CCN1CCCC(=O)C1=CC=C(F)C=C1 LNEPOXFFQSENCJ-UHFFFAOYSA-N 0.000 title abstract 6
- 229960003878 haloperidol Drugs 0.000 title abstract 3
- 150000002168 ethanoic acid esters Chemical class 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 1
- 239000003921 oil Substances 0.000 abstract 1
- 235000019198 oils Nutrition 0.000 abstract 1
- XAMUDJHXFNRLCY-UHFFFAOYSA-N phenthoate Chemical compound CCOC(=O)C(SP(=S)(OC)OC)C1=CC=CC=C1 XAMUDJHXFNRLCY-UHFFFAOYSA-N 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 235000011803 sesame oil Nutrition 0.000 abstract 1
- 239000008159 sesame oil Substances 0.000 abstract 1
- 235000015112 vegetable and seed oil Nutrition 0.000 abstract 1
- 239000008158 vegetable oil Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/52—Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Anesthesiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Hydrogenated Pyridines (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Saccharide Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Cephalosporin Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB868621892A GB8621892D0 (en) | 1986-09-11 | 1986-09-11 | Organic compound |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL83819A0 IL83819A0 (en) | 1988-02-29 |
| IL83819A true IL83819A (en) | 1992-02-16 |
Family
ID=10604021
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL83819A IL83819A (en) | 1986-09-11 | 1987-09-08 | Acetic acid ester of haloperidol and pharmaceutical compositions thereof |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US4855307A (da) |
| EP (1) | EP0260070B1 (da) |
| JP (1) | JPS6377857A (da) |
| AT (1) | ATE92917T1 (da) |
| AU (1) | AU591334B2 (da) |
| DE (1) | DE3786966T2 (da) |
| DK (1) | DK166320C (da) |
| ES (1) | ES2058120T3 (da) |
| FI (1) | FI88155C (da) |
| GB (1) | GB8621892D0 (da) |
| IE (1) | IE60902B1 (da) |
| IL (1) | IL83819A (da) |
| NO (1) | NO169893C (da) |
| NZ (1) | NZ221711A (da) |
| PT (1) | PT85678B (da) |
| ZA (1) | ZA876819B (da) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3742580C1 (de) * | 1987-12-16 | 1989-05-11 | Schaper & Bruemmer Gmbh | Verwendung des alpha,alpha-Diphenyl-alpha-(3-carboxy-propionyloxy)-essigsaeure-4-(N-methylpiperidyl)-esters zur Behandlung hypertoner Funktionszustaende im Bereich der Harnblase |
| US5776963A (en) | 1989-05-19 | 1998-07-07 | Hoechst Marion Roussel, Inc. | 3-(heteroaryl)-1- (2,3-dihydro-1h-isoindol-2-yl)alkyl!pyrrolidines and 3-(heteroaryl)-1- (2,3-dihydro-1h-indol-1-yl)alkyl!pyrrolidines and related compounds and their therapeutic untility |
| DK238190D0 (da) * | 1990-10-03 | 1990-10-03 | Lundbeck & Co As H | Depotderivater |
| ATE348808T1 (de) | 2000-03-06 | 2007-01-15 | Acadia Pharm Inc | Azacyclische verbindungen zur verwendung in der behandlung von mit serotonin verwandten krankheiten |
| EP1787984B1 (en) * | 2000-03-06 | 2016-10-19 | Acadia Pharmaceuticals Inc. | Azacyclic compounds for use in the treatment of serotonin related diseases |
| WO2003057698A2 (en) | 2001-12-28 | 2003-07-17 | Acadia Pharmaceuticals, Inc. | Spiroazacyclic compounds as monoamine receptor modulators |
| US7538222B2 (en) | 2002-06-24 | 2009-05-26 | Acadia Pharmaceuticals, Inc. | N-substituted piperidine derivatives as serotonin receptor agents |
| WO2004000808A2 (en) | 2002-06-24 | 2003-12-31 | Acadia Pharmaceuticals Inc. | N-substituted piperidine derivatives as serotonin receptor agents |
| US7253186B2 (en) | 2002-06-24 | 2007-08-07 | Carl-Magnus Andersson | N-substituted piperidine derivatives as serotonin receptor agents |
| SI1587789T1 (sl) | 2003-01-16 | 2009-02-28 | Acadia Pharm Inc | Selektivni inverzni agonisti serotoninskega 2A/2Creceptorja kot terapevtiki za nevrodegenerativne bolezni |
| US7820695B2 (en) | 2004-05-21 | 2010-10-26 | Acadia Pharmaceuticals, Inc. | Selective serotonin receptor inverse agonists as therapeutics for disease |
| US20050261278A1 (en) | 2004-05-21 | 2005-11-24 | Weiner David M | Selective serotonin receptor inverse agonists as therapeutics for disease |
| ES2412207T3 (es) | 2004-09-27 | 2013-07-10 | Acadia Pharmaceuticals Inc. | Forma cristalina de hemitartrato de N-(4-fluorobencil)-N-(1-metilpiperidin-4-il)-N'-(4-(2-metilpropiloxi)fenilmetil)carbamida |
| US7790899B2 (en) | 2004-09-27 | 2010-09-07 | Acadia Pharmaceuticals, Inc. | Synthesis of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and crystalline forms |
| AU2008228833B9 (en) | 2007-03-19 | 2013-10-24 | Acadia Pharmaceuticals Inc. | Combinations of 5-HT2A inverse agonists and antagonists with antipsychotics |
| HUE055763T2 (hu) | 2015-07-20 | 2021-12-28 | Acadia Pharm Inc | Eljárás N-(4-fluorbenzil)-N-(1-metilpiperidin-4-il)-N'-(4-(2-metil-propil-oxi)fenil-metil)karbamid vagy ennek tartarát-sója és C polimorf formája elõállítására |
| WO2017165635A1 (en) | 2016-03-25 | 2017-09-28 | Acadia Pharmaceuticals Inc. | Combination of pimavanserin and cytochrome p450 modulators |
| US10953000B2 (en) | 2016-03-25 | 2021-03-23 | Acadia Pharmaceuticals Inc. | Combination of pimavanserin and cytochrome P450 modulators |
| US11464768B2 (en) | 2016-12-20 | 2022-10-11 | Acadia Pharmaceuticals Inc. | Pimavanserin alone or in combination for use in the treatment of Alzheimer's disease psychosis |
| WO2018200977A1 (en) | 2017-04-28 | 2018-11-01 | Acadia Pharmaceuticals Inc. | Pimavanserin for treating impulse control disorder |
| EP3675827A1 (en) | 2017-08-30 | 2020-07-08 | Acadia Pharmaceuticals Inc. | Formulations of pimavanserin |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB895309A (en) * | 1959-11-18 | 1962-05-02 | Res Lab Dr C Janssen Nv | Pyrrolidine and piperidine derivatives |
| US3408356A (en) * | 1965-08-31 | 1968-10-29 | Squibb & Sons Inc | Long chain esters of 4'-fluoro-4-[4-hydroxy-4-(alpha, alpha, alpha-trifluorotolyl)piperi-dino]butyrophenone and the like |
| DE1695194A1 (de) * | 1966-07-11 | 1971-03-18 | Hoffmann La Roche | Verfahren zur Herstellung von Piperidinderivaten |
| US4070473A (en) * | 1973-01-26 | 1978-01-24 | Ab Ferrosan | Piperidino-butyrophenones |
| JPS568318A (en) * | 1979-06-28 | 1981-01-28 | Janssen Pharmaceutica Nv | Non oral long acting composition of haloperidol and bromperidol derivative |
-
1986
- 1986-09-11 GB GB868621892A patent/GB8621892D0/en active Pending
-
1987
- 1987-09-03 AT AT87307799T patent/ATE92917T1/de not_active IP Right Cessation
- 1987-09-03 ES ES87307799T patent/ES2058120T3/es not_active Expired - Lifetime
- 1987-09-03 EP EP87307799A patent/EP0260070B1/en not_active Expired - Lifetime
- 1987-09-03 DE DE87307799T patent/DE3786966T2/de not_active Expired - Lifetime
- 1987-09-03 IE IE236687A patent/IE60902B1/en not_active IP Right Cessation
- 1987-09-04 US US07/093,404 patent/US4855307A/en not_active Expired - Lifetime
- 1987-09-08 IL IL83819A patent/IL83819A/xx not_active IP Right Cessation
- 1987-09-08 NZ NZ221711A patent/NZ221711A/xx unknown
- 1987-09-10 AU AU78232/87A patent/AU591334B2/en not_active Ceased
- 1987-09-10 PT PT85678A patent/PT85678B/pt not_active IP Right Cessation
- 1987-09-10 NO NO873785A patent/NO169893C/no unknown
- 1987-09-10 FI FI873924A patent/FI88155C/fi not_active IP Right Cessation
- 1987-09-11 DK DK479587A patent/DK166320C/da not_active IP Right Cessation
- 1987-09-11 ZA ZA876819A patent/ZA876819B/xx unknown
- 1987-09-11 JP JP62226744A patent/JPS6377857A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| IE60902B1 (en) | 1994-08-24 |
| US4855307A (en) | 1989-08-08 |
| EP0260070B1 (en) | 1993-08-11 |
| JPS6377857A (ja) | 1988-04-08 |
| FI873924L (fi) | 1988-03-12 |
| ATE92917T1 (de) | 1993-08-15 |
| PT85678B (pt) | 1990-05-31 |
| PT85678A (en) | 1987-10-01 |
| DK479587A (da) | 1988-03-12 |
| AU7823287A (en) | 1988-03-17 |
| IL83819A0 (en) | 1988-02-29 |
| NO873785L (no) | 1988-03-14 |
| DE3786966T2 (de) | 1994-03-17 |
| DK166320C (da) | 1993-08-23 |
| AU591334B2 (en) | 1989-11-30 |
| EP0260070A1 (en) | 1988-03-16 |
| FI88155C (fi) | 1993-04-13 |
| NO169893C (no) | 1992-08-19 |
| GB8621892D0 (en) | 1986-10-15 |
| DK166320B (da) | 1993-04-05 |
| ZA876819B (en) | 1988-06-29 |
| NO169893B (no) | 1992-05-11 |
| DK479587D0 (da) | 1987-09-11 |
| FI88155B (fi) | 1992-12-31 |
| NZ221711A (en) | 1989-11-28 |
| ES2058120T3 (es) | 1994-11-01 |
| IE872366L (en) | 1988-03-11 |
| FI873924A0 (fi) | 1987-09-10 |
| NO873785D0 (no) | 1987-09-10 |
| DE3786966D1 (de) | 1993-09-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL83819A0 (en) | Acetic acid ester of haloperidol and pharmaceutical compositions thereof | |
| ES2074846T3 (es) | Nuevas naftil-etil-ureas y naftil-etil-tioureas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen. | |
| ES485540A1 (es) | Procedimiento para la obtencion de 1,4-dihidropiridinas, congrupos ester funcionalizados | |
| FI945703A0 (fi) | 3,4,4-trisybstituoitujen piperidinyyli-N-alkyylikarboksylaattien ja välituotteiden valmistus | |
| ATE2271T1 (de) | 4-(substituierte thiazolyl)-3-hydroxy-3-pyrrolin2,5-dion-verbindungen, verfahren zur herstellung und sie enthaltende pharmazeutische zusammensetzung. | |
| DE69122866D1 (de) | Herstellung von substituierten piperidinen | |
| AU6748081A (en) | 3,4,5-trihydroxy piperidines | |
| ZA838666B (en) | 1'-ethoxycarbonyloxyethyl ester of valproic acid,its preparation and pharmaceutical compositions containing it | |
| FI850449A0 (fi) | Foerfarande foer framstaellning av (-) -trans-4-(4-fluorfenyl)-3-(4-metoxifenoxi)-metylpiperidin eller farmaceutiskt godtagbara syraadditionssalter daerav. | |
| HUT52374A (en) | Process for producing pharmaceutical compositions | |
| ATE22804T1 (de) | Pharmazeutische zusammensetzung. | |
| DE69022162D1 (de) | Polyester-Mischung, ihre Herstellung und Verwendung. | |
| ATE78693T1 (de) | Ein dideoxynukleosid enthaltendes arzneimittel. | |
| NO891260D0 (no) | Fremgangsmaate for fremstilling av 4-aryl-4-piperidin (eller pyrrolidin eller hexahydroazepin) carbinoler. | |
| DE69018755D1 (de) | Verfahren zur Herstellung von 3-(L-Pyroglutamyl)-L-thiazolidin-4-carbonsäure-Derivaten. | |
| EP0191724A3 (de) | 1,4-Dihydropyridine, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen | |
| AU3181084A (en) | 2,6-bis-fluoromethyl-dihydropyridine-3, 5-dicarboxylic | |
| DE69007738D1 (de) | Haarbehandlungsmittel. | |
| DE69715733D1 (de) | Verfahren zur Herstellung von 5-Brom-2-Fluorbenzolboronsäure | |
| DE3762854D1 (de) | Pharmazeutische zusammensetzungen mit inhalt von 5-phenyl-1,3-dioxoalkenylverbindungen. | |
| SE8505801L (sv) | I,4-dihydropyridin-derivat, deras framstellning och farmaceutiska beredningar innehallande dessa | |
| DE3854557D1 (de) | Stickstoffhaltige ester von carboxylgruppenhaltigen copolymerisaten. | |
| DE59204444D1 (de) | Verfahren zur herstellung von epoxygruppen aufweisenden organosiliciumverbindungen. | |
| DE3670629D1 (de) | Ester von cyclopropancarbonsaeure und 2,3-dihydro-4-phenyl-1h-inden-2-ol, ihre herstellung, ihre verwendung als parasitizide und sie enthaltende zusammensetzungen. | |
| DE59200530D1 (de) | Verwendung von 1,4-Dihydropyridinen zur Herstellung eines Arzneimittels, zur Behandlung von Neuropathien, die durch Diabetes mellitus verursacht sind. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RH | Patent void |